ScholarIQanswers from OpenAlex

Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications

PaperCitations, authors & open-access status

Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications have?

ScholarIQcitation count

Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications has 23 citations in the OpenAlex counts ScholarIQ stores.

When was Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications published?

ScholarIQyear

Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications has 2023 year in the ScholarIQ index.

What is the open-access status of Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications?

ScholarIQoa status

Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications has gold oa status in the ScholarIQ index.

What is the DOI of Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications?

ScholarIQdoi

The DOI for Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications is on the source record.

What is the PMID of Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications?

ScholarIQpmid

The PMID for Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications is on the source record.

What is the OpenAlex record for Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications?

ScholarIQopenalex

The OpenAlex for Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial